Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
New York, NY
SEC filing record 1 source field available
Fiscal year end
31 December
Protara Therapeutics, Inc. has filed 783 SEC EDGAR filings since 14 Apr 2006

SEC filing history

Showing 26-50 of 778 matching filings.

Per page
25
Current page
2
424B7 File 333-279067

PROSPECTUS SUPPLEMENT

Filing date
02 Feb 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
27 Jan 2026
Reporting date
26 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
27 Jan 2026
Reporting date
26 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
27 Jan 2026
Reporting date
26 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
27 Jan 2026
Reporting date
26 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
22 Jan 2026
Reporting date
20 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
22 Jan 2026
Reporting date
20 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
22 Jan 2026
Reporting date
20 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
22 Jan 2026
Reporting date
20 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
21 Jan 2026
Reporting date
16 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
21 Jan 2026
Reporting date
16 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
21 Jan 2026
Reporting date
16 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
21 Jan 2026
Reporting date
16 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
21 Jan 2026
Reporting date
16 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
21 Jan 2026
Reporting date
16 Jan 2026
SEC evidence
Open document Open filing
Next action
Verify source filing
SCHEDULE 13G/A File 005-88372

SCHEDULE 13G/A filing

Filing date
21 Jan 2026
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36694

CURRENT REPORT

Filing date
15 Dec 2025
Reporting date
15 Dec 2025
Next action
Verify source filing
424B7 File 333-279067

PROSPECTUS SUPPLEMENT

Filing date
09 Dec 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36694

CURRENT REPORT

Filing date
08 Dec 2025
Reporting date
04 Dec 2025
Next action
Verify source filing
424B5 File 333-275290

PROSPECTUS SUPPLEMENT

Filing date
05 Dec 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-275290

PROSPECTUS SUPPLEMENT

Filing date
04 Dec 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36694

CURRENT REPORT

Filing date
03 Dec 2025
Reporting date
03 Dec 2025
Next action
Verify source filing
8-K File 001-36694

CURRENT REPORT

Filing date
19 Nov 2025
Reporting date
19 Nov 2025
Next action
Verify source filing
SCHEDULE 13G/A File 005-88372

SCHEDULE 13G/A filing

Filing date
14 Nov 2025
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-36694

QUARTERLY REPORT

Filing date
10 Nov 2025
Reporting date
30 Sep 2025
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .